Pictet Asset Management (Switzerland)’s CRISPR Therapeutics CRSP Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$487K	Hold
2023 Q1	$392K	Hold
2022 Q4	$353K	Sell
2022 Q3	$2.37M	Sell
2022 Q2	$25.7M	Buy
2022 Q1	$245K	Hold
2021 Q4	$296K	Hold
2021 Q3	$437K	Buy